Adrian Schomburg, CEO at Eisbach Bio

News

Eisbach Bio receives 4.2 million euros

The biotech company Eisbach Bio is receiving support from Texas: The Cancer Focus Fund is investing 4.2 million euros (4.5 million dollars) in…

German Biotechnology Report 2019 Biotech

News

How Munich biotech startups are fighting cancer

Munich is one of Germany's leading biotech hubs. Research is conducted here on a wide variety of medications and therapies, including cancer. We…

Adrian Schomburg, CEO at Eisbach Bio

News

Eisbach Bio receives 6.7 million euros from the Bavarian State Government

The Munich-based biotech company Eisbach Bio has received funding of 6.7 million euros for the development of antiviral agents against…

Eisbach Bio Pieris Pharmaceuticals Financing

News

Eisbach Bio receives 8 million euros in state funding

Eisbach Bio has received funding from the German Federal Ministry of Education and Research (BMBF) for the clinical development of a COVID-19 drug…